Loss of heterozygosity or intragenic mutation, which comes first?

American Journal of Pathology

Volumn 158, Issue 5, 2001, Pages 1561-1563

  Wilentz, Robb E ^a,b   Argani, Pedram ^a   Hruban, Ralph H ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; PROTEIN P53; SMAD4 PROTEIN; UNCLASSIFIED DRUG;

CANCER GRADING; CARCINOGENESIS; CARCINOMA IN SITU; CHROMOSOME 17P; CHROMOSOME 18Q; CHROMOSOME 9P; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR GENETICS; NOTE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL;

EID: 0035004853     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64109-0     Document Type: Note

References (21)

1. Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis
2. Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma
3. Genetic progression and divergence in pancreatic carcinoma
4. Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: Loss of intranuclear expression
5. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: Evidence that DPC4 inactivation occurs late in neoplastic progression
6. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia
7. Overexpression of p53 protein in adenocarcinoma of the pancreas
8. BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: Evidence and implications
9. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma
10. Pancreatic intraepithelial neoplasia (PanlN): A new nomenclature and classification system for pancreatic duct lesions
11. Progression model for pancreatic cancer
12. A genetic model for colorectal tumorigenesis
13. Genetic alterations during colorectal-tumor development
14. Mechanisms underlying losses of heterozygosity in human colorectal cancers
15. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
16. Homozygous deletion map at 18q21.1 in pancreatic cancer
17. DPC4 gene in various tumor types
18. Tumor-suppressive pathways in pancreatic carcinoma
19. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms
20. Immunohistochemical labeling for Dpc4 mirrors genetic status in pancreatic: A new marker of DPC4 inactivation
21. Allelotype of pancreatic adenocarcinoma using xenograft enrichment